An enhancer element responsive to ras and fms signaling pathways is composed of two distinct nuclear factor binding sites. (original) (raw)

Journal Article

,

1Department of Microbiology and Immunology, Duke University Medical Center, Durham, North Carolina 27710.

Search for other works by this author on:

,

1Department of Microbiology and Immunology, Duke University Medical Center, Durham, North Carolina 27710.

Search for other works by this author on:

,

1Department of Microbiology and Immunology, Duke University Medical Center, Durham, North Carolina 27710.

Search for other works by this author on:

1Department of Microbiology and Immunology, Duke University Medical Center, Durham, North Carolina 27710.

Search for other works by this author on:

Cite

M A Reddy, S J Langer, M S Colman, M C Ostrowski, An enhancer element responsive to ras and fms signaling pathways is composed of two distinct nuclear factor binding sites., Molecular Endocrinology, Volume 6, Issue 7, 1 July 1992, Pages 1051–1060, https://doi.org/10.1210/mend.6.7.1324418
Close

Navbar Search Filter Mobile Enter search term Search

Abstract

In order to precisely define the sequences that constitute the ras-responsive enhancers element present in the murine retrotransposon NVL3, point mutations were introduced into the previously defined minimal transcriptional enhancer DNA. Analyses of the effects of these point mutations in transient transfection experiments, in gel retention assays, and by methylation interference footprinting indicated that the enhancer element was composed of two binding sites for distinct nuclear factors. Both binding sites were required for activation of the enhancer by either ras or v-fms oncogenes, and the distinct nuclear factors were found in extracts from cells that contained either oncogene. UV cross-linking analysis revealed that the AP1-related binding site, TGACTCT, was recognized by a nuclear factor of apparent molecular size of 50 kilodaltons, that is probably c-jun. The other binding site, CAGGATAT, is very similar to sites recognized by the ets-family of transcription factors, and was recognized by the 120-kilodalton ras-responsive factor-1. Activation of the NVL3 element was reconstituted in an in vitro transcription assay. The ets-related binding site was necessary for this in vitro reconstitution of activity. Thus, the NVL3 enhancer is related to the previously described oncogene-responsive enhancer element present in polyoma virus and is also related to elements identified in several cellular genes known to be ras-responsive, including the transforming growth factor-beta 1 gene.

This content is only available as a PDF.

Copyright © 1992 by The Endocrine Society

Citations

Views

Altmetric

Metrics

Total Views 209

13 Pageviews

196 PDF Downloads

Since 2/1/2017

Month: Total Views:
February 2017 3
December 2017 2
January 2018 3
February 2018 7
March 2018 2
April 2018 8
May 2018 5
June 2018 3
July 2018 2
August 2018 1
September 2018 6
October 2018 2
November 2018 7
December 2018 3
January 2019 4
February 2019 3
March 2019 8
April 2019 6
May 2019 3
June 2019 2
July 2019 2
August 2019 3
September 2019 1
October 2019 9
November 2019 5
December 2019 3
January 2020 4
February 2020 3
March 2020 11
April 2020 2
May 2020 4
June 2020 1
July 2020 2
August 2020 4
September 2020 2
October 2020 1
December 2020 3
January 2021 6
February 2021 2
March 2021 1
April 2021 5
June 2021 3
July 2021 1
August 2021 1
September 2021 3
October 2021 6
November 2021 4
December 2021 1
January 2022 1
February 2022 1
March 2022 3
April 2022 3
June 2022 1
July 2022 1
August 2022 2
December 2022 2
April 2023 1
June 2023 1
August 2023 1
September 2023 1
October 2023 2
November 2023 3
December 2023 1
March 2024 1
April 2024 2
May 2024 1
June 2024 1
July 2024 3
September 2024 4

×

Email alerts

More on this topic

Citing articles via

More from Oxford Academic